Anti-SARS-CoV-2 RBD Antibody (dilutions start from 4ug/ml) can bind to Immobilized SARS-CoV-2 RBD, His tag(S0A2008) at 0.5μg/ml (50μL/well) as coating antigen.
EC50=5.215ng/ml
| Host | Human |
| Antigen | SARS-CoV-2 |
| Accession | P0DTC2 |
| Clone Number | SDT-R004 |
| Antibody Type | Human mAb |
| Application | ELISA |
| Reactivity | SARS-CoV-2 |
| Cross Reactivity | Has cross-reactivity in ELISA with: SARS-CoV-2 (BA.2/Omicron) RBD, His Tag (S0A2003) SARS-CoV-2 (BA.2.12.1/Omicron) RBD, His Tag (S0A2015) SARS-CoV-2 (BA.4&BA.5/Omicron) RBD, His Tag (S0A2004) No cross-reactivity in ELISA with: SARS-CoV-2 (BA.2.75/Omicron) RBD |
| Purification | Protein A |
| Concentration | 1.2mg/ml |
| Conjugation | Unconjugated |
| Physical Appearance | Liquid |
| Storage Buffer | PBS, 40% Glycerol, 0.05%BSA, 0.03% Proclin 300 |
| Stability & Storage | 12 months from date of receipt / reconstitution, -20 °C as supplied |
| application | dilution | species |
| ELISA | 0.001-0.05μg/ml | null |
Sars-cov-2 (2019-NCOV) infects human respiratory epithelial cells through binding to human ACE2 receptors. Spike protein is a large type I transmembrane protein containing two subunits S1 and S2.S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing cell surface receptors. S2 contains the basic elements required for membrane fusion. S protein plays a key role in inducing neutralizing antibody and T cell responses as well as protective immunity.

Anti-SARS-CoV-2 RBD Antibody (dilutions start from 4ug/ml) can bind to Immobilized SARS-CoV-2 RBD, His tag(S0A2008) at 0.5μg/ml (50μL/well) as coating antigen.
EC50=5.215ng/ml
